137 Results
Sort By:
Published on December 20, 2023
Despite strong financial headwinds, venture capital (VC) firms continue to provide biotech startups with the critical cash they need to develop and scale their technology. Check out five of the most established VCs betting on life sciences companies. Biotech startups promise potentially groundbreaking solutions to major illnesses such as cancer,…
Published on October 19, 2023
By Mike May, PhD Katherine Dunn, DPhilsenior lecturerUniversity of Edinburgh Blood tests play a crucial role in diagnosing cancer and tracking the impact of a treatment, but their potential far outstrips their current uses. For example, the cellular composition of a blood sample may suggest that…
Published on August 8, 2023
William A. Haseltine, PhD Hepatitis C is a serious disease that affects more than 58 million people globally.1 Although endemic in many countries, it is possible to eliminate the disease within entire populations. Unfortunately, this has only been done in a limited number of countries. Here…
Published on July 18, 2023
Computational Biology company PrecisionLife released research that identifies 73 genes that are highly associated with the severe and fatigue dominant forms of long COVID. The results of the study were published on the preprint server medRxiv. The research provides a detailed genetic look into long COVID and also draws commonalities…
Published on May 11, 2023
A $100 million gift from Gene Lay, the founder and CEO of antibody and reagents company BioLegend, will establish The Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital. Other organizations involved with the new institute include Massachusetts General Hospital and Harvard Medical School (HMS). Vijay Kuchroo,…
Published on April 19, 2023
A new medical and research center focused on neuroimmune axis disorders named the Metrodora Institute, based in Salt Lake City, announced its launch today with the goal of accelerating the development of better diagnostics and therapeutics for this under-researched class of diseases. According to the Institute, it will gather resources…
Published on February 10, 2023
An explosion in big data is sweeping through the healthcare space, and biopharma companies are eager to capitalize on abundant clinical data from the real world, or real-world evidence (RWE). These five RWE providers are attracting big investments for their potential to streamline precision healthcare and boost drug development. For…
Published on February 10, 2023
Sponsored content brought to you by Dr. Achim von Leoprechting Dr. Achim von Leoprechting became CEO of Tecan in 2019. Under his watch during the COVID-19 pandemic, Tecan boosted its profile as a global leader in innovative and scalable solutions for the most pressing issues…
Published on December 20, 2022
More and more large biobanks and studies are being set up to collect a huge array of different health related data, including genetic or genomic information, to help facilitate a new era of preventative precision medicine. It is becoming increasingly clear that participants in these studies want and deserve to…
Published on November 11, 2022
An all-in-one lab kit comprised of many pinhead-sized magnets inside a handheld unit has been developed by UCLA researchers. They say it could significantly increase the speed and volume of infectious disease testing, while reducing the costs and usage of scarce supplies. The researchers say these kits can be easily…
Published on October 14, 2022
The All of Us project aims to enroll a million volunteers, as do the Mount Sinai Million Health Discoveries Program and the Taiwan Precision Medicine Initiative. U.K. Biobank already has 500,000 participants and has made the entire genomes of 200,000 people available to scientists—the world’s largest single release of whole-genome…
Published on October 14, 2022
Sponsored content brought to you by Gary Pestano, PhD Gary Pestano, PhD, is the chief development officer at Biodesix, Inc., a solutions-based diagnostics company. Biodesix has leveraged Droplet Digital™ PCR (ddPCR™) for molecular biomarker research and clinical sample testing for years, taking advantage of the technology’s…
Published on September 1, 2022
Precision diagnostics company IncellDx announced on Wednesday that its incellKINE Long COVID in vitro diagnostic has received a CE-IVD marking in Europe, the first test of its kind approved for marketing to diagnose patient with Post-Acute Sequelae of COVID-19 (PASC), commonly known as long COVID. The test, which demonstrated greater…
Published on August 16, 2022
The COVID-19 pandemic has really highlighted the need for effective genomic pathogen surveillance and allowed researchers around the world to hone their skills and technology. While these advances are not in doubt, whether they are maintained and used to help prevent new pandemics and fight global threats such as antimicrobial…
Published on August 16, 2022
Artificial intelligence (AI) has the potential to improve many areas of medicine, with drug development as a key focus. Many companies are now working to apply the power of AI to design better drugs, but six companies are leading the race with candidates already in clinical trials. Over the last…